Subscription and demo access


 
About Interfax
Press Releases
Products & Services
Contact us
Customer Login
 


Headlines
 

02/06 09:00   RUSSIA AND FSU GENERAL NEWS
 
02/05 22:29   Poroshenko to urge Rada to amend law on administration of justice in absentia to punish those guilty of Maidan killings
 
02/05 22:03   NATO mulling organization of NATO-Russia Council meeting - secretariat source
 
02/05 22:00   Russia expects U.S. to pay attention to UN recommendations on opposing racial discrimination
 
02/05 21:53   Contact Group meeting to be held on Feb 10 in form of videoconference - Pushilin
 
02/05 21:41   Number of incidents of Ukrainian military shelling of DPR territory increased dozens of times recently - Zakharchenko
 
02/05 21:16   CSTO should coordinate steps in light of migration crisis in Europe - secretary general
 
02/05 20:48   Meeting between Pope, Patriarch of Moscow to mark new stage in relations between two churches - joint statement
 
02/05 20:48   Russian Eurobonds return to previous levels by end of week after fall at start of month
 
02/05 20:45   Russian foreign ministry: all Russian strikes carried out solely against sites of militants in Syria, their location verified through Baghdad Information Center (Part 2)
 




 

Interfax.com  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...


News headlines


July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at eng.editors@interfax.ru)

/Interfax/
 Subscription
You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.
Title:


Phone:


E-mail:


First name:


Company:


Country:
Last name:


Division:


City:
Products:
Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

February 06, 2016
 
09:00
RUSSIA AND FSU GENERAL NEWS
 
February 05, 2016
 
22:29
Poroshenko to urge Rada to amend law on administration of justice in absentia to punish those guilty of Maidan killings
 
22:03
NATO mulling organization of NATO-Russia Council meeting - secretariat source
 
22:00
Russia expects U.S. to pay attention to UN recommendations on opposing racial discrimination
 
21:53
Contact Group meeting to be held on Feb 10 in form of videoconference - Pushilin
 
21:41
Number of incidents of Ukrainian military shelling of DPR territory increased dozens of times recently - Zakharchenko
 
21:16
CSTO should coordinate steps in light of migration crisis in Europe - secretary general
 
20:48
Meeting between Pope, Patriarch of Moscow to mark new stage in relations between two churches - joint statement
 
20:48
 
20:45
Russian foreign ministry: all Russian strikes carried out solely against sites of militants in Syria, their location verified through Baghdad Information Center (Part 2)
 
20:30
Intl community not to recognize Donbas elections if they are held without Kyiv clearance - Kuchma
 
20:14
Russian, Chinese foreign ministers concerned about N. Korea's plans to launch space vehicle, call for resuming six-party talks (Part 2)
 
19:58
Russian revenues from hydrocarbons decrease to 45% - Medvedev (Part 2)
 
19:52
Main indexes of the Russia stock market for February 5
 
 more headlines 



Interviews
 

.
U.S. Under Secretary of State for Arms Control and International Security State Rose Gottemoeller has given an interview to Interfax in which she speaks about U.S.-Russian issues over the INF Treaty and states that the United States is not going to return to the IV stage of its missile shield in Europe and not going to return nuclear arms to the Korean peninsula.

more
.
.
Russian Foreign Minister Sergei Lavrov has given an interview to Interfax in which he sums up results of 2015, in particular with regard to Ukraine and Syria, and tells about Russia‘s foreign political agenda in 2016.

more
.
.
Egyptian Ambassador to Russia Mohammed El-Badri has given an interview to Interfax in which he speaks about the investigation of Russia‘s A321 air crash over Egypt, safety of flights over the Sinai Peninsula, the influence of the tragedy on tourist flow to Egypt and Russian-Egyptian bilateral relations.

more

 
  
 ©   1991—2016   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:  Interfax.ru   |   IFX.RU   |   Interfax Group   Rambler's Top100